Science Explorer Interactive view Map
Institution · The Woodlands · United States

The US Oncology Network

In research, The US Oncology Network stands highest in Health Sciences (#9,710 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Economics and Econometrics and Economics, Econometrics and Finance — Economics and Econometrics is 14.3× its share of world research.

usoncology.comROR OpenAlex
World rank, 2022–2025
#21,384
of 28,054 · #28,947 all time
Rank in United States
#3,152
of 4,192
Research works
295
▲ 59% vs 2013–17
Citations
5.1k
17.3 per fractional work
Top-10% rate
8.8%
record average 16.5%
Open access
28%
world 28%

What is The US Oncology Network known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #9,710 of 11,982 11.9%63 #13684

Each strip is that field’s whole ranked pool, with the notch where The US Oncology Network sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does The US Oncology Network specialise in?

Where its research is concentrated relative to its size: Economics and Econometrics takes 14.3× the share of its output that it takes of world research.

  1. Economics and EconometricsSubfield · 25.6 works14×
  2. Economics, Econometrics and FinanceField · 25.6 works11×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.79× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 3.52× its world share, 4 worksImmunology and Micro…Neuroscience: 0.12× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.65× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.03× its world share, 0 worksChemistryComputer Science: 0.37× its world share, 3 worksComputer ScienceEngineering: 0.07× its world share, 1 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.03× its world share, 0 worksMaterials ScienceMathematics: 0.30× its world share, 0 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyDentistry: 0.15× its world share, 0 worksDentistryHealth Professions: 1.99× its world share, 6 worksHealth ProfessionsMedicine: 2.64× its world share, 57 worksMedicineNursing: 0.20× its world share, 0 worksNursingArts and Humanities: 0.04× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.09× its world share, 0 worksBusiness, Management…Decision Sciences: 0.04× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 10.62× its world share, 26 worksEconomics, Econometr…Psychology: 0.32× its world share, 1 worksPsychologySocial Sciences: 0.11× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 10.6×. Every wedge is a field page.

Who are the top researchers at The US Oncology Network?

Ranked on the composite score, R. Coleman lead among researchers whose main affiliation is The US Oncology Network.

  1. 1 R. Coleman United States · #745,281 worldwide 31 citations · 16 works
All ranked researchers at The US Oncology Network

Which keywords describe research at The US Oncology Network?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cost of Care, Financial Toxicity, Chemotherapy, Quality of Life, Clinical Trials, Cost-effectiveness Analysis, Health Utility Measures and Targeted Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cost of Care14▲ 431×1 topic
  2. Financial Toxicity14▲ 431×1 topic
  3. Chemotherapy12▲ 16×21 topics
  4. Quality of Life12▲ 7.5×15 topics
  5. Clinical Trials11▲ 15×10 topics
  6. Cost-effectiveness Analysis8▲ 82×1 topic
  7. Health Utility Measures8▲ 82×1 topic
  8. Targeted Therapy7▲ 26×4 topics
  9. Biomarkers6▲ 7.4×4 topics
  10. Breast Cancer6▲ 21×7 topics
  11. Immunotherapy5▲ 6.6×13 topics
  12. Ovarian Cancer5▲ 51×2 topics
  13. Metastasis5▲ 13×8 topics
  14. Genomic Profiling4▲ 39×2 topics
  15. Tumor Microenvironment4▲ 9.1×8 topics
  16. Precision Medicine4▲ 7.5×5 topics
  17. Radiotherapy4▲ 8.9×10 topics
  18. Clinical Practice Guidelines4▲ 5.9×10 topics
  19. Metastatic Breast Cancer3▲ 52×2 topics
  20. Treatment Guidelines3▲ 14×2 topics
  21. ALK Inhibitors3▲ 45×1 topic
  22. EGFR Mutations3▲ 45×1 topic
  23. Ethical Considerations3▲ 8.4×5 topics
  24. Cytoreductive Surgery3▲ 42×2 topics
  25. Genomic Analysis3▲ 11×2 topics
  26. Monoclonal Antibodies3▲ 30×3 topics
  27. Mutation Analysis3▲ 37×1 topic
  28. Pharmaceutical Industry3▲ 70×2 topics
  29. Prognostic Factors3▲ 6.2×10 topics
  30. Tumor Models3▲ 46×1 topic
  31. Immune Checkpoint Blockade3▲ 23×1 topic
  32. PD-1 and PD-L13▲ 23×1 topic
  33. Survival Analysis3▲ 9.4×7 topics
  34. Clinical Outcomes3▲ 12×3 topics
  35. Drug Development Costs3▲ 96×1 topic
  36. Elderly3▲ 9.9×3 topics
  37. Generic Drugs3▲ 96×1 topic
  38. Biopharmaceuticals3▲ 47×2 topics
  39. Cancer Incidence3▲ 18×4 topics
  40. Immunogenicity3▲ 56×2 topics

Which research topics does The US Oncology Network publish most on?

By volume in 2022–2025: Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life, Lung Cancer Treatments and Mutations and Ovarian cancer diagnosis and treatment.

Economic and Financial I…14Economic and Financial Impacts of Cancer: 14 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 8 fractional worksLung Cancer Treatments and Mutations: 3 fractional worksOvarian cancer diagnosis and treatment: 3 fractional worksCancer Immunotherapy and Biomarkers: 3 fractional worksPharmaceutical Economics and Policy: 3 fractional worksBiosimilars and Bioanalytical Methods: 3 fractional worksPalliative Care and End-of-Life Issues: 2 fractional worksPharmaceutical Practices and Patient Outcomes: 2 fractional worksBRCA gene mutations in cancer: 2 fractional works
Economics and EconometricsPulmonary and Respiratory MedicineReproductive MedicineOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Economic and Financial Impacts of Cancer Economics and Econometrics 14 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  4. 4 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
  6. 6 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 3 works
  8. 8 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 2 works
  9. 9 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 2 works
  10. 10 BRCA gene mutations in cancer Genetics 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.4%not open71.6%

World: 28% of research is openly available.

with international co-authors20.0%domestic only80.0%

World: 19% is written across borders.

How has The US Oncology Network's research output changed?

Output in 2018–2022 was 59% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in The Woodlands

All research institutions in The Woodlands

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.